BXPHARMACompany

Beximco Pharmaceuticals PLC. (BXPHARMA) Share Price, Chart & Fundamentals

Beximco Pharmaceuticals PLC. is listed on the Dhaka Stock Exchange under the ticker BXPHARMA. This page carries the price history chart for BXPHARMA and lets you practice buying and selling it with virtual money, under the same trading hours, settlement delay and commission the real market applies.

BXPHARMA price history

Chart data is derived from the published Dhaka Stock Exchange day-end archive. It can lag or contain gaps and should never be treated as an official quote.

Company Fundamentals & Valuation

Audited financial ratios and DSE exchange disclosures for BXPHARMA

Listed 1986
P/E (Audited)10.89
Annual EPS৳13.07
NAVPS (Book Value)৳107.48
Dividend Yield3.39%
52-Week Trading RangeCurrent: ৳145.7
52W Low: ৳99.552W High: ৳158.5
Shareholding PatternSep 30, 2026
Sponsor:30.13%
Institute:25.79%
Foreign:26.96%
Public:17.12%
Historical Dividend Declarations
20243.4% yield
40% Cash
20232.4% yield
35% Cash
20222.3% yield
35% Cash
20212.0% yield
35% Cash

Corporate Disclosures & DSE News

Official Price Sensitive Information (PSI) and filings for BXPHARMA

Boss News Perks

Hold BXPHARMA in your portfolio?

Boss Tier subscribers get access to the Portfolio News Radar, automatically scanning all active holdings and highlighting critical dividend declarations and PSI updates.

Upgrade to Boss (৳20/mo)
Notice29 Oct 2026

BXPHARMA: Price Limit Open

There will be no price limit on the trading of the shares of the Company today (29.10.2026) following its corporate declaration.

Dividend29 Oct 2026

BXPHARMA: Dividend Declaration

$15

Notice26 Oct 2026

BXPHARMA: Change of Board Meeting Time under LR 19(1)

The Company has further informed that, the Board meeting under LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on October 28, 2026 at 4:00 PM instead of 5:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2026.

Notice25 Oct 2026

BXPHARMA: Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2026 at 5:00 PM to consider, among others, annual audited financial statements of the Company for the year ended June 30, 2026.

Notice02 Aug 2026

BXPHARMA: Resumption after Record Date

Trading of the shares of the company will resume on 03-Aug-2026.

Notice30 Jul 2026

BXPHARMA: Suspension for Record Date

Trading of the shares of the company will remain suspended on record date i.e., 02-Aug-2026.

Notice28 Jul 2026

BXPHARMA: Spot News

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 29.07.2026 to 30.07.2026 and trading of the shares will remain suspended on record date i.e., 02.08.2026.

Rating16 Jul 2026

BXPHARMA: Credit Rating Result

Credit Rating Information and Services PLC (CRISL) has assigned the rating of the Company as "AAA" in the long term and "ST-1" for short term along with Stable outlook in consideration of its audited financials up to June 30, 2025 also unaudited financials up to March 31, 2026 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

Financials24 Jun 2026

BXPHARMA: Q2 Financials

$16

Financials24 Jun 2026

BXPHARMA: Q3 Financials

(Q3 Un-audited): Consolidated EPS was Tk. 4.98 for January-March 2026 as against Tk. 3.86 for January-March 2025; Consolidated EPS was Tk. 15.56 for July 2025-March 2026 as against Tk. 11.73 for July 2024-March 2025. Consolidated NOCFPS was Tk. 16.74 for July 2025-March 2026 as against Tk. 9.46 for July 2024-March 2025. Consolidated NAV per share was Tk. 134.60 as on March 31, 2026 and Tk. 115.21 as on March 31, 2025. (Q3 Un-audited): Consolidated EPS was Tk. 3.86 for January-March 2025 as against Tk. 3.06 for January-March 2024; Consolidated EPS was Tk. 11.73 for July 2024-March 2025 as against Tk. 9.75 for July 2023-March 2024. Consolidated NOCFPS was Tk. 9.46 for July 2024-March 2025 as against Tk. 14.79 for July 2023-March 2024. Consolidated NAV per share was Tk. 115.21 as on March 31, 2025 and Tk. 104.17 as on March 31, 2024.

How trading BXPHARMA works here

Nothing is loosened to make practice easier. An order for BXPHARMA is accepted only while the Dhaka Stock Exchange is open, commission is deducted the way a broker would deduct it, and shares cannot be sold until they have settled: two trading days after purchase for categories A, B, G and N, three for category Z.

Exchange
DSE
Ticker
BXPHARMA
Trading hours
10:00 to 14:15
Settlement
T+2
Commission
0.40%
Practice balance
৳10,000

What kind of listing BXPHARMA is

This is an ordinary equity listing on the Dhaka Stock Exchange. Buying a share means owning a small stake in the business, and the share price responds to earnings, dividends, sector conditions and overall market sentiment.

Ordinary shares are the most straightforward instrument to learn on, which is why most people start here before touching funds or bonds.

External Market Tools for BXPHARMA

Audited financial ratios, annual EPS, NAVPS, 52-week price range and dividend history for BXPHARMA are published above. For external community discussions or alternative screener tools, you can also inspect BXPHARMA on third-party market sites.

We do not use StockNow data, and this link is neither sponsored nor affiliated.

View BXPHARMA on StockNow

We are not responsible for the content of that site or for anything you do there.

Execute Trade

Market Price

৳145.70

You must log in to trade stocks

Log In to Trade

Practice BXPHARMA risk-free

Test an idea on BXPHARMA with virtual money in the full trading terminal, alongside the rest of your practice portfolio.

Open the trading terminal

BXPHARMA questions people ask

What is the DSE ticker symbol for Beximco Pharmaceuticals PLC.?

Beximco Pharmaceuticals PLC. trades on the Dhaka Stock Exchange under the ticker BXPHARMA (PharmaChem sector, Category A, listed in 1986). You use that symbol to look the company up on the exchange, with a broker, or inside the StockSimulatorBD practice terminal.

Where can I view BXPHARMA's audited P/E ratio, EPS, and dividend history?

According to Dhaka Stock Exchange disclosures published on this StockSimulatorBD page, BXPHARMA has a reference share price of ৳145.7, audited P/E ratio of 10.89, annual EPS of ৳13.07, NAVPS (book value) of ৳107.48, dividend yield of 3.39%, 52-week trading range of ৳99.5 to ৳158.5. In 2024, BXPHARMA declared 40% cash dividend.

Can I practice trading BXPHARMA without real money?

Yes. StockSimulatorBD lets you buy and sell BXPHARMA using a virtual balance. Orders follow the same rules the real market applies, including authentic DSE trading hours (10:00 to 14:15 BST), T+2/T+3 settlement lots (by market category) and a 0.40% commission, but no real money is ever involved and the balance cannot be withdrawn.

Do I need a BO account to analyze or trade BXPHARMA here?

No. A BO (Beneficiary Owner) account with a licensed broker is required to buy BXPHARMA for real on the Dhaka Stock Exchange, but not to practice on StockSimulatorBD. Many investors audit company fundamentals and rehearse trades here before opening a broker account.

When can I trade BXPHARMA?

The Dhaka Stock Exchange trades Sunday to Thursday from 10:00 to 14:15 Bangladesh Standard Time (BST) and is closed on Friday, Saturday and public holidays. The simulator enforces the same schedule, so BXPHARMA orders are only accepted while the real market is open.

Other DSE company listings

Browse all DSE listings